# 21 CFR 211 PREAMBLE - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/preamble/21-cfr-211-preamble/c840be82-c9e9-4a22-8eee-ecd5df9dce86

> FDA guidance document: 21 CFR 211 PREAMBLE. Issue date: September 29, 1978. Get complete insights and analysis.

---

## Details

- Title: 21 CFR 211 PREAMBLE
- Communication Type: Preamble
- Product Type: drugs
- Office Name: Department of Health and Human Services, Food and Drug Administration
- Office URL: /offices/food-and-drug-administration/437fdb2a-5048-42aa-aaea-ea28efe65516
- Issue Date: 1978-09-29

## Related Documents

- [E22 General Considerations for Patient Preference Studies](https://www.globalkeysolutions.net/guidances/guidance-document/e22-general-considerations-for-patient-preference-studies/3b39fdd6-9dd0-4536-9f4d-dc3bddcc1267)
- [M15 General Principles for Model-Informed Drug Development](https://www.globalkeysolutions.net/guidances/guidance-document/m15-general-principles-for-model-informed-drug-development/0c262249-637c-4377-ac7f-9fc2fa0ab688)
- [M14 General Principles on Plan, Design, and Analysis of Pharmacoepidemiological Studies That Utilize Real-World Data for Safety Assessment of Medicines](https://www.globalkeysolutions.net/guidances/guidance-document/m14-general-principles-on-plan-design-and-analysis-of-pharmacoepidemiological-studies-that-utilize-real-world-data-for-safety-assessment-of-medicines/90dcd460-563e-47bc-a95b-fd98dc534067)